Sakakura Yasunori, Hosokawa Yoichiro, Tsuruga Eichi, Irie Kazuharu, Nakamura Masanori, Yajima Toshihiko
Department of Oral Anatomy, School of Dentistry, Health Sciences University of Hokkaido, 1757 Kanazawa, Ishikari-Tobetsu, Hokkaido 061-0293, Japan.
Cell Tissue Res. 2007 Apr;328(1):137-51. doi: 10.1007/s00441-006-0329-7. Epub 2006 Nov 29.
The middle portion of Meckel's cartilage (one of four portions that disappear with unique fate) degrades via hypertrophy and the cell death of chondrocytes and via the resorption of cartilage by chondroclasts. We have examined the immunolocalization of matrix metalloproteinase-2 (MMP-2), MMP-9, MMP-13, and MMP-14 (members of the MMP activation cascade) and galectin-3 (an endogenous substrate for MMP-9 and an anti-apoptotic factor) during resorption of Meckel's cartilage in embryonic mice and have compared the results with those of developing endochondral bones in hind limbs. MMP immunoreactivity, except for MMP-2, is present in nearly all chondrocytes in the middle portion of Meckel's cartilage. On embryonic day 15 (E15), faint MMP-2-immunoreactive and intense MMP-13-immunoreactive signals occur in the periosteal bone matrix deposited by periosteal osteoblasts on the lateral surface, whereas MMP-9 and MMP-14 are immunolocalized in the peripheral chondrocytes of Meckel's cartilage. The activation cascade of MMPs by face-to-face cross-talk between cells may thus contribute to the initiation of Meckel's cartilage degradation. On E16, immunopositive signaling for MMP-13 is detectable in the ruffled border of chondroclasts at the resorption front, whereas immunostaining for galectin-3 is present at all stages of chondrocyte differentiation, especially in hypertrophic chondrocytes adjacent to chondroclasts. Galectin-3-positive hypertrophic chondrocytes may therefore coordinate the resorption of calcified cartilage through cell-to-cell contact with chondroclasts. In metatarsal specimens from E16, MMPs are detected in osteoblasts, young osteocytes, and the bone matrix of the periosteal envelope, whereas galectin-3 immunoreactivity is intense in young periosteal osteocytes. In addition, intense MMP-9 and MMP-14 immunostaining has been preferentially found in pre-hypertrophic chondrocytes, although galectin-3 immunoreactivity markedly decreases in hypertrophic chondrocytes. These results indicate that the degradation of Meckel's cartilage involves an activation cascade of MMPs that differs from that in endochondral bone formation.
梅克尔软骨的中间部分(四个具有独特命运而消失的部分之一)通过软骨细胞的肥大和细胞死亡以及破骨细胞对软骨的吸收而降解。我们研究了基质金属蛋白酶-2(MMP-2)、MMP-9、MMP-13和MMP-14(MMP激活级联的成员)以及半乳糖凝集素-3(MMP-9的内源性底物和抗凋亡因子)在胚胎小鼠梅克尔软骨吸收过程中的免疫定位,并将结果与后肢发育中的软骨内骨进行了比较。除MMP-2外,MMP免疫反应性存在于梅克尔软骨中间部分几乎所有的软骨细胞中。在胚胎第15天(E15),微弱的MMP-2免疫反应性信号和强烈的MMP-13免疫反应性信号出现在外侧表面由骨膜成骨细胞沉积的骨膜骨基质中,而MMP-9和MMP-14免疫定位在梅克尔软骨的周边软骨细胞中。因此,细胞间面对面的相互作用导致的MMP激活级联可能有助于梅克尔软骨降解的启动。在E16时,在吸收前沿破骨细胞的皱褶边缘可检测到MMP-13的免疫阳性信号,而半乳糖凝集素-3的免疫染色出现在软骨细胞分化的所有阶段,尤其是在与破骨细胞相邻的肥大软骨细胞中。因此,半乳糖凝集素-3阳性的肥大软骨细胞可能通过与破骨细胞的细胞间接触来协调钙化软骨的吸收。在E16的跖骨标本中,MMPs在成骨细胞、年轻骨细胞和骨膜包膜的骨基质中被检测到,而半乳糖凝集素-3免疫反应性在年轻的骨膜成骨细胞中很强。此外,虽然半乳糖凝集素-3免疫反应性在肥大软骨细胞中明显降低,但强烈的MMP-9和MMP-14免疫染色优先出现在前肥大软骨细胞中。这些结果表明,梅克尔软骨的降解涉及一个与软骨内骨形成不同的MMP激活级联。